May 04, 2023
Consumers on Wednesday asked the Eleventh Circuit to rethink its decision to undo an $8 million class settlement in a suit over a brain performance supplement, saying the objector to the deal didn't show he was injured by his purchase of the supplement.
April 12, 2023
The Eleventh Circuit on Wednesday vacated an $8 million class settlement in a suit over a brain performance supplement, saying the consumers lacked standing since they didn't claim that they planned to buy the supplements again in the future.
March 02, 2023
A public interest attorney told an Eleventh Circuit panel on Thursday that a lower court wrongly approved an $8 million class settlement in a suit over a brain performance supplement, saying it provides no real value to class members, and that the $2.9 million attorney fee is too high.
March 01, 2023
In March, federal circuit courts will take on the constitutionality of the Consumer Product Safety Commission, wrestle with how to distinguish between mergers and acquisitions in an insurance policy dispute and again address whether delivery drivers are subject to the Federal Arbitration Act. Here, Law360 previews selected appellate arguments in the month ahead.
August 16, 2022
A U.K-based company accused of falsely advertising its celebrity-endorsed brain supplement has asked the Eleventh Circuit to reject a "serial objector's" attempt to derail an $8 million class action settlement, arguing there is no evidence the deal was not negotiated fairly.
June 15, 2022
An attorney who purchased an allegedly misleading brain performance supplement has asked the Eleventh Circuit to reverse approval of an up to $8 million class settlement against its makers, saying the $2.9 million attorney fee component is too high and the settlement is not worth what it purports to be.